The Δ32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population

被引:25
作者
Degerli, N [1 ]
Yilmaz, E [1 ]
Bardakci, F [1 ]
机构
[1] Cumhuriyet Univ, Dept Biol, Fac Sci & Literature, TR-58140 Sivas, Turkey
关键词
receptor; CCR5-Delta; 32; allele; cancer; genetic polymorphism; Turkish;
D O I
10.1016/j.clinbiochem.2004.11.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: In the present study, we determined the frequency of Delta32 allele distribution and its relationship with various carcinomas in a Turkish population. Design and methods: We determined the allelic frequency of CCR5-Delta32 in 267 healthy individuals as well as 39 breast, 34 laryngeal, 30 thyroid and 20 brain carcinomas in a Turkish population using polymerase chain reaction (PCR). Results: The frequency Of mutant Delta32 alleles in the Turkish population was 2.18%. The population was in the Hardy-Weinberg equilibrium. The frequency of the mutant allele was the highest in patients with breast carcinoma (3.85%) among all the carcinomas studied, but there was no statistically significant relationship (P = 0.334). Conclusion: The frequency of the Delta32 allele detected in the Turkish population was slightly lower in comparison with the previous reports. The frequency of heterozygote genotypes remained an independent risk factor for the development of breast cancer (odd ratio = 1.628; confidence intervals = 0.442-5.992) as well as other cancers examined in this study. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:248 / 252
页数:5
相关论文
共 37 条
[1]  
BALCELLOS LF, 2000, IMMUNOGENETICS, V51, P281
[2]   The CCR5 deletion mutation fails to protect against multiple sclerosis [J].
Bennetts, BH ;
Teutsch, SM ;
Buhler, MM ;
Heard, RNS ;
Stewart, GJ .
HUMAN IMMUNOLOGY, 1997, 58 (01) :52-59
[3]   Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences [J].
Carrington, M ;
Dean, M ;
Martin, MP ;
O'Brien, SJ .
HUMAN MOLECULAR GENETICS, 1999, 8 (10) :1939-1945
[4]   Novel alleles of the chemokine-receptor gene CCR5 [J].
Carrington, M ;
Kissner, T ;
Gerrard, B ;
Ivanov, S ;
O'Brien, SJ ;
Dean, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (06) :1261-1267
[5]   The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention [J].
Cascieri, MA ;
Springer, MS .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (04) :420-427
[6]  
Dean M, 1999, CANCER RES, V59, P3561
[7]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[8]   Lack of association of CCR2-64I and CCR5-Δ32 with type 1 diabetes and latent autoimmune diabetes in adults [J].
Gambelunghe, G ;
Ghaderi, M ;
Brozzetti, A ;
Del Sindaco, P ;
Gharizadeh, B ;
Nyren, P ;
Hjelmström, P ;
Nikitina-Zake, L ;
Sanjeevi, CB ;
Falorni, A .
HUMAN IMMUNOLOGY, 2003, 64 (06) :629-632
[9]  
Goedert JJ, 2000, SEMIN ONCOL, V27, P390
[10]   Cytokine response to endotoxin in individuals heterozygous for the Δ32 mutation of chemokine receptor CCR5 [J].
Heesen, M ;
Schippers, EF ;
Bloemeke, B ;
Kunz, D ;
van Dissel, JT .
CYTOKINE, 2003, 21 (04) :195-199